Zydus Lifesciences to Introduce Advanced Cancer Tests in India

[{ "selector": ".fwgpf-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateX(calc(360px - 291px)) scale(0.15)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateX(0px) scale(1)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".bxblm-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }]

Exclusive Deal with Myriad Genetics

Zydus Lifesciences has signed an exclusive agreement with US-based Myriad Genetics to introduce advanced cancer risk and tumour diagnostic tests in the Indian market.

[{ "selector": ".rtaro-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".zabjl-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

Three Key Tests Coming Soon
The agreement includes MyRisk® hereditary cancer test, MyChoice® HRD Plus, and Prolaris® prostate cancer test, helping doctors assess risk and guide treatment decisions.

[{ "selector": ".gbccb-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".fcuzf-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

Boost to Cancer Care in India

These tests support personalised, evidence-based cancer care and can help patients and clinicians make better treatment decisions earlier.

[{ "selector": ".doxom-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".ekajd-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }] Click Here

Healthcare Impact

The partnership strengthens precision diagnostics availability in India, potentially improving early detection and long-term outcomes.

[{ "selector": ".bxrks-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".xpsbn-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

With Our Subscription Plans

[{ "selector": ".xxjel-a", "duration": "500ms", "fill": "forwards", "delay": "0ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".mikds-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".wljje-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateX(-299px)", "opacity": "1", "visibility" :"visible" }, {"offset": 1, "transform": "translateX(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".prkep-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-33px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }] Open Demat A/C

Zydus Lifesciences to Introduce Advanced Cancer Tests in India

Exclusive Deal with Myriad Genetics Zydus Lifesciences has signed an exclusive agreement with US-based Myriad Genetics to introduce advanced cancer risk and tumour diagnostic tests in the Indian market.

Three Key Tests Coming Soon The agreement includes MyRisk® hereditary cancer test, MyChoice® HRD Plus, and Prolaris® prostate cancer test, helping doctors assess risk and guide treatment decisions.

Boost to Cancer Care in IndiaThese tests support personalised, evidence-based cancer care and can help patients and clinicians make better treatment decisions earlier.

Healthcare ImpactThe partnership strengthens precision diagnostics availability in India, potentially improving early detection and long-term outcomes.

With Our Subscription Plans

Open demat account in 5 minutes*

Exclusive Deal with Myriad Genetics

Zydus Lifesciences has signed an exclusive agreement with US-based Myriad Genetics to introduce advanced cancer risk and tumour diagnostic tests in the Indian market.

Three Key Tests Coming Soon
The agreement includes MyRisk® hereditary cancer test, MyChoice® HRD Plus, and Prolaris® prostate cancer test, helping doctors assess risk and guide treatment decisions.

Boost to Cancer Care in India

These tests support personalised, evidence-based cancer care and can help patients and clinicians make better treatment decisions earlier.

Healthcare Impact

The partnership strengthens precision diagnostics availability in India, potentially improving early detection and long-term outcomes.